跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,482 条关于
“BK nephropathy”
全部
3,482
临床试验
3,110
药物
69
机构
7
资讯
296
去年
Study Calls for Optimization of High-Cost IVIG Therapy in BK Nephropathy Treatment
2个月前
Ipsen to Acquire Memo Therapeutics in Deal Worth Over €700 Million, Securing Phase II BK Polyomavirus Antibody Potravitug
去年
Memo Therapeutics AG Completes Enrollment in Phase II Trial of Potravitug for BK Viremia
去年
Memo Therapeutics AG Completes Enrollment in Phase II Trial of Potravitug for BK Viremia
去年
Memo Therapeutics Completes Enrollment in Phase II Trial of Potravitug for BK Viremia
去年
Memo Therapeutics AG Completes Enrollment in Phase II Trial of Potravitug for BK Viremia
去年
Memo Therapeutics to Present Phase II Results for First-in-Class BK Polyomavirus Treatment at World Transplant Congress
去年
Memo Therapeutics Demonstrates Therapeutic Antibodies Can Cross Kidney Barrier, Supporting BK Virus Treatment Approach
9个月前
Memo Therapeutics' Potravitug Receives EU Orphan Designation for BK Polyomavirus Infection in Kidney Transplant Patients
3个月前
Potravitug Demonstrates Statistically Significant Viral Clearance in Phase II BK Polyomavirus Trial, Paving Way for Pivotal Phase III
第 1 页,共 30 页
上一页
下一页